ACAZEN

Serial Number 79275472
Registration 6253453
700

Registration Progress

Application Filed
Nov 21, 2019
Under Examination
Approved for Publication
Nov 10, 2020
Published for Opposition
Nov 10, 2020
Registered
Jan 26, 2021

Trademark Image

ACAZEN

Basic Information

Serial Number
79275472
Registration Number
6253453
Filing Date
November 21, 2019
Registration Date
January 26, 2021
Published for Opposition
November 10, 2020
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 26, 2021
Registration
Registered
Classes
005

Rights Holder

Alpinia Institute for Life Sciences AG

25
Address
Bahnhofstrasse 34
CH-8880 Walenstadt
CH

Ownership History

Alpinia Laudanum Institute of Phytopharmaceutical Sciences AG

Original Applicant
25
CH

Alpinia Laudanum Institute of Phytopharmaceutical Sciences AG

Owner at Publication
25
CH

Alpinia Institute for Life Sciences AG

Original Registrant
25
CH

Legal Representation

Attorney
Frank W. Compagni

USPTO Deadlines

Next Deadline
552 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-01-26)
Due Date
January 26, 2027
Grace Period Ends
July 26, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

29 events
Date Code Type Description Documents
Jun 7, 2021 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
May 15, 2021 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Apr 30, 2021 XXSS O GENERIC MADRID TRANSACTION SENT TO IB Loading...
Apr 29, 2021 XXCR P GENERIC MADRID TRANSACTION CREATED Loading...
Apr 26, 2021 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jan 26, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 10, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 10, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 8, 2020 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Oct 21, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 21, 2020 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Oct 21, 2020 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Oct 6, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Oct 6, 2020 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Oct 6, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Oct 6, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Oct 6, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 25, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 24, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 24, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 10, 2020 RFNT P REFUSAL PROCESSED BY IB Loading...
Mar 24, 2020 RFRR P REFUSAL PROCESSED BY MPU Loading...
Mar 24, 2020 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Mar 4, 2020 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Mar 3, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 25, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 14, 2020 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jan 8, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 2, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Nutritional supplements for medical use; medicines, particularly phytopharmaceutical products, namely, pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); active plant agents and plant extracts for medical use, namely, plant extracts for pharmaceutical purposes; pharmaceutical, veterinary and sanitary products, namely, pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); dietetic substances in the nature of food and beverages for medical use, food for babies; adjuvants for medical use; amino acids for medical use; anesthetics; analgesics; vermifuges; antibiotics; biological preparations for medical use, namely, biological preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); chemical products for medical use, namely, chemical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); chemical reagents for medical or veterinary use; chemico-pharmaceutical products, namely, chemical-pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); ferments for pharmaceutical use; hormones for medical use; medical infusions for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); medicines for dental use, namely, medicines for treating dentalirritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); medicines for human medicine, namely, pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); radiological contrast substances for medical use; steroids
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005